• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非病毒性肝癌病因。

Non-viral causes of hepatocellular carcinoma.

机构信息

Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

World J Gastroenterol. 2010 Aug 7;16(29):3603-15. doi: 10.3748/wjg.v16.i29.3603.

DOI:10.3748/wjg.v16.i29.3603
PMID:20677332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2915420/
Abstract

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and represents an international public health concern as one of the most deadly cancers worldwide. The main etiology of HCC is chronic infection with hepatitis B and hepatitis C viruses. However, there are other important factors that contribute to the international burden of HCC. Among these are obesity, diabetes, non-alcoholic steatohepatitis and dietary exposures. Emerging evidence suggests that the etiology of many cases of HCC is in fact multifactorial, encompassing infectious etiologies, comorbid conditions and environmental exposures. Clarification of relevant non-viral causes of HCC will aid in preventative efforts to curb the rising incidence of this disease.

摘要

肝细胞癌 (HCC) 是最常见的原发性肝脏恶性肿瘤,也是全球最致命癌症之一,因此成为国际公共卫生关注的重点。HCC 的主要病因是乙型肝炎和丙型肝炎病毒的慢性感染。然而,还有其他一些重要因素导致 HCC 在全球的负担加重。其中包括肥胖、糖尿病、非酒精性脂肪性肝炎和饮食暴露。新出现的证据表明,实际上许多 HCC 病例的病因是多因素的,包括感染病因、合并症和环境暴露。阐明 HCC 的相关非病毒病因将有助于预防工作,以遏制这种疾病发病率的上升。

相似文献

1
Non-viral causes of hepatocellular carcinoma.非病毒性肝癌病因。
World J Gastroenterol. 2010 Aug 7;16(29):3603-15. doi: 10.3748/wjg.v16.i29.3603.
2
[Role of environmental factors in the etiology of hepatocellular carcinoma].[环境因素在肝细胞癌病因学中的作用]
Orv Hetil. 2010 Jul 11;151(28):1132-6. doi: 10.1556/OH.2010.28913.
3
Hepatocellular carcinoma--epidemiological trends and risk factors.肝细胞癌——流行病学趋势与风险因素
Dig Dis. 2009;27(2):80-92. doi: 10.1159/000218339. Epub 2009 Jun 22.
4
Environmental factors and risk for hepatocellular carcinoma.环境因素与肝细胞癌风险
Gastroenterology. 2004 Nov;127(5 Suppl 1):S72-8. doi: 10.1016/j.gastro.2004.09.018.
5
Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.肝癌:描述性流行病学及除乙肝和丙肝病毒感染之外的危险因素
Cancer Lett. 2009 Dec 1;286(1):9-14. doi: 10.1016/j.canlet.2008.10.040. Epub 2008 Dec 16.
6
[Epidemiology, risk factors and molecular pathogenesis of primary liver cancer].[原发性肝癌的流行病学、危险因素及分子发病机制]
Orv Hetil. 2008 Mar 23;149(12):541-8. doi: 10.1556/OH.2008.28313.
7
Mutations of the HFE gene and the risk of hepatocellular carcinoma.HFE基因的突变与肝细胞癌风险
Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):350-3. doi: 10.1006/bcmd.1999.0263.
8
Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.波兰肝硬化患者的铁过载和 HFE 基因突变。
Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):270-5. doi: 10.1016/s1499-3872(11)60045-3.
9
Prevention of hepatocellular carcinoma in nonviral-related liver diseases.非病毒性肝病中肝细胞癌的预防
J Gastroenterol Hepatol. 2009 May;24(5):712-9. doi: 10.1111/j.1440-1746.2009.05776.x.
10
Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.肝硬化患者的肝脏铁、HFE基因突变与肝细胞癌的发生
Gastroenterology. 2008 Jan;134(1):102-10. doi: 10.1053/j.gastro.2007.10.038. Epub 2007 Oct 26.

引用本文的文献

1
Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Biomarker in Advanced Hepatocellular Carcinoma Treated with First-Line Immunotherapy.中性粒细胞与淋巴细胞比值(NLR)作为一线免疫治疗晚期肝细胞癌的预测生物标志物
J Gastrointest Cancer. 2025 Aug 19;56(1):175. doi: 10.1007/s12029-025-01299-5.
2
Prediction of Multi-targeting Pharmacological Activity of Bioactive Compounds from Medicinal Plants Against Hepatocellular Carcinoma Through Advanced Network Pharmacology and Bioinformatics-Based Investigation.通过基于先进网络药理学和生物信息学的研究预测药用植物生物活性化合物对肝细胞癌的多靶点药理活性
Appl Biochem Biotechnol. 2025 May;197(5):2979-3007. doi: 10.1007/s12010-024-05150-8. Epub 2025 Jan 16.
3
Therapeutic Potential of Hongjam in A Diethylnitrosamine and Thioacetamide-induced Hepatocellular Carcinoma Mouse Model.红参在二乙基亚硝胺和硫代乙酰胺诱导的小鼠肝癌模型中的治疗潜力
J Cancer Prev. 2024 Dec 30;29(4):165-174. doi: 10.15430/JCP.24.029.
4
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.肝癌发病率和治疗效果的种族差异。
Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1821. doi: 10.1002/cnr2.1821. Epub 2023 Jun 21.
5
Enhancement of treatment efficacy of hepatic tumours using Trans-arterial-chemoembolization.经动脉化疗栓塞术提高肝肿瘤治疗效果
Am J Cancer Res. 2023 May 15;13(5):1623-1639. eCollection 2023.
6
Synthesis and Characterization of N-Labeled Aflatoxin B-Formamidopyrimidines and Aflatoxin B-N7-Guanine from a Partial Double-Stranded Oligodeoxynucleotide as Internal Standards for Mass Spectrometric Measurements.以部分双链寡脱氧核苷酸为质谱测定内标合成并表征 N 标记的黄曲霉毒素 B 型甲酰胺嘧啶和黄曲霉毒素 B-N7-鸟嘌呤
ACS Omega. 2023 Apr 11;8(16):14841-14854. doi: 10.1021/acsomega.3c01328. eCollection 2023 Apr 25.
7
Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem.乙型肝炎病毒相关性肝细胞癌:一个持续存在的全球性问题。
Braz J Microbiol. 2023 Jun;54(2):679-689. doi: 10.1007/s42770-023-00970-y. Epub 2023 Apr 14.
8
Exposure to Air Pollution and Survival in Follow-Up after Hepatocellular Carcinoma.肝细胞癌患者接触空气污染与随访期生存情况
Liver Cancer. 2022 Jun 15;11(5):474-482. doi: 10.1159/000525346. eCollection 2022 Sep.
9
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances.晚期肝细胞癌的免疫疗法:从临床试验到真实世界数据及未来进展
World J Clin Oncol. 2022 Jun 24;13(6):448-472. doi: 10.5306/wjco.v13.i6.448.
10
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures.埃及肝细胞癌的独特情况:流行病学与控制措施综述
World J Gastrointest Oncol. 2021 Dec 15;13(12):1919-1938. doi: 10.4251/wjgo.v13.i12.1919.

本文引用的文献

1
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者的肝细胞癌
J Gastroenterol. 2009;44 Suppl 19:89-95. doi: 10.1007/s00535-008-2262-x. Epub 2009 Jan 16.
2
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.肥胖和糖尿病对肝细胞癌风险的影响。
Ann Oncol. 2009 Feb;20(2):353-7. doi: 10.1093/annonc/mdn565. Epub 2008 Aug 22.
3
The epidemiology of obesity: the size of the problem.肥胖症流行病学:问题的规模。
J Intern Med. 2008 Apr;263(4):336-52. doi: 10.1111/j.1365-2796.2008.01922.x. Epub 2008 Feb 27.
4
Malignant transformation of hepatic adenomas.肝腺瘤的恶性转化
Mod Pathol. 2008 Apr;21(4):491-7. doi: 10.1038/modpathol.2008.8. Epub 2008 Feb 1.
5
Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.肝硬化患者的肝脏铁、HFE基因突变与肝细胞癌的发生
Gastroenterology. 2008 Jan;134(1):102-10. doi: 10.1053/j.gastro.2007.10.038. Epub 2007 Oct 26.
6
Coffee and cancer risk: an update.咖啡与癌症风险:最新进展
Eur J Cancer Prev. 2007 Oct;16(5):385-9. doi: 10.1097/01.cej.0000243853.12728.76.
7
Shattuck Lecture. We can do better--improving the health of the American people.沙塔克讲座。我们可以做得更好——改善美国人民的健康。
N Engl J Med. 2007 Sep 20;357(12):1221-8. doi: 10.1056/NEJMsa073350.
8
Nutrients intake and the risk of hepatocellular carcinoma in Italy.意大利的营养摄入与肝细胞癌风险
Eur J Cancer. 2007 Nov;43(16):2381-7. doi: 10.1016/j.ejca.2007.07.012. Epub 2007 Aug 23.
9
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies.超重、肥胖与肝癌风险:队列研究的荟萃分析
Br J Cancer. 2007 Oct 8;97(7):1005-8. doi: 10.1038/sj.bjc.6603932. Epub 2007 Aug 14.
10
Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.咖啡饮用与肝细胞癌风险:一项荟萃分析。
Hepatology. 2007 Aug;46(2):430-5. doi: 10.1002/hep.21708.